More importantly, the enhancement of imiquimod‐induced apoptosis by the combination of NF‐κB inhibitor and chemotherapeutic agents may represent a logical alternative approach in melanoma therapy that should be more vigorously tested. This evidence concerns the gene NFKB1 and melanoma.